Top Moderna Competitors and Alternatives | Bullfincher

Moderna +

+

Company

Moderna

Ticker

MRNA

Headquarter

Cambridge ,MA

US

CEO

Mr. Stephane Bancel

Industry

Biotechnology

Stock Price

Stock Price

Market Cap

$10.24 B

Employees

Years

2022
2023
2024

Employees

3.90 K
5.60 K
5.80 K

Y/Y

44.44%

43.59%

3.57%

Revenue Per Employee

Years

2022
2023
2024

Revenue Per Employee

$4.94 M
$1.22 M
$557.93 K

Y/Y

24.81%

75.24%

54.37%

Net Income Per Employee

Years

2022
2023
2024

Net Income Per Employee

$2.14 M
-$841.79 K
-$613.97 K

Y/Y

52.56%

139.26%

27.06%

Income Statement

Revenue

Years

2022
2023
2024

Revenue

$19.26 B
$6.85 B
$3.24 B

Y/Y

8.61%

64.45%

52.75%

Revenue by Products / Services

Revenue by Geography

Research and Development

Years

2022
2023
2024

Research and Development

$3.30 B
$4.85 B
$4.54 B

Y/Y

65.49%

47.04%

6.23%

Operating Income

Years

2022
2023
2024

Operating Income

$9.42 B
-$4.24 B
-$3.95 B

Y/Y

29.15%

145%

6.94%

Tax Rate (%)

Years

2022
2023
2024

Tax Rate (%)

13.00%
-20.00%
1.00%

Y/Y

55.46%

254.54%

106.54%

Net Income

Years

2022
2023
2024

Net Income

$8.36 B
-$4.71 B
-$3.56 B

Y/Y

31.47%

156.37%

24.46%

Assets & Liabilities | Cash Flow

Total Assets

Years

2022
2023
2024

Total Assets

$25.86 B
$18.43 B
$14.14 B

Y/Y

4.82%

28.74%

23.25%

Total Liabilities

Years

2022
2023
2024

Total Liabilities

$6.74 B
$4.57 B
$3.24 B

Y/Y

36%

32.12%

29.11%

Capital Expenditures (Capex)

Years

2022
2023
2024

Capital Expenditures (Capex)

-$400.00 M
-$707.00 M
-$1.05 B

Y/Y

40.85%

76.75%

48.66%

Profitability

Operating Income Margin (%)

Years

2022
2023
2024

Operating Income Margin (%)

48.90%
-61.90%
-121.91%

Y/Y

34.77%

226.58%

96.95%

Net Income Margin (%)

Years

2022
2023
2024

Net Income Margin (%)

43.41%
-68.84%
-110.04%

Y/Y

36.9%

258.58%

59.85%

EBITDA

2021	13528000000.00
2022	9768000000.00
2023	-3283000000.00
2024	-3394000000.00

Years

2022
2023
2024

EBITDA

$9.77 B
-$-3.28 B
-$-3.39 B

Y/Y

27.79%

133.61%

3.38%

Free Cash Flow (FCF)

2021	13336000000.00
2022	4581000000.00
2023	-3825000000.00
2024	-4055000000.00

Years

2022
2023
2024

Free Cash Flow (FCF)

$4.58 B
-$3.83 B
-$4.06 B

Y/Y

65.65%

183.5%

6.01%

Ratios

Return on Equity (ROE)

Years

2022
2023
2024

Return on Equity (ROE)

43.73%
-34.03%
-32.67%

Y/Y

49.3%

177.82%

4%

Return on Assets (ROA)

Years

2022
2023
2024

Return on Assets (ROA)

32.34%
-25.58%
-25.18%

Y/Y

34.61%

179.1%

1.56%

Debt to Equity

Years

2022
2023
2024

Debt to Equity

0.00%
8.97%
6.51%

Y/Y

0%

100%

27.42%

Valuation

Enterprise Value

Years

2022
2023
2024

Enterprise value

$67.57 B
$36.33 B
$14.75 B

Y/Y

29.26%

46.24%

59.4%

Enterprise value to Revenue

Years

2022
2023
2024

Enterprise value to Revenue

3.51
5.30
4.56

Y/Y

34.86%

51.24%

14.07%

Enterprise value to EBITDA

Years

2022
2023
2024

Enterprise value to EBITDA

6.92
-11.06
-4.35

Y/Y

2.02%

259.97%

60.72%